- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
NephroGenex Inc+ Add to Watchlist
NRX:US4.8700 USD 0.2016 4.32%
As of 20:10:00 ET on 12/26/2014.
Company Profile for NephroGenex Inc (NRX)
NephroGenex, Inc. develops novel drugs for the treatment of kidney disease. The Company is developing a small molecule drug that acts as an inhibitor of the pathogenic oxidative chemistries which are elevated in diabetic patients.
Key Executives for NephroGenex Inc (NRX)
|Pierre LegaultChief Executive Officer||J Wesley FoxPres/Chief Scientific Officer|
|John P HamillCFO/Treasurer/Secretary||Bob PetersonVP:Product Dev|